Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200623 | SCV000251192 | benign | not specified | 2014-07-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000949252 | SCV000602631 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000200623 | SCV000711832 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Val205Ile in exon 5 of BCS1L: This variant is not expected to have clinical si gnificance because it has been identified in 5.64% (644/11418) of Latino chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs148278887). |
Genomic Research Center, |
RCV000714568 | SCV000845270 | likely benign | BCS1L-related disorder | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000949252 | SCV001095502 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001137961 | SCV001297961 | uncertain significance | Mitochondrial complex III deficiency nuclear type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001137962 | SCV001297962 | benign | Leigh syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001137963 | SCV001297963 | benign | GRACILE syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Natera, |
RCV001137963 | SCV001455776 | benign | GRACILE syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV000714568 | SCV004736388 | benign | BCS1L-related disorder | 2019-09-25 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |